PENNY MILLIGAN: Open Payments
NPI 1184974032 · CHATTANOOGA, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,000 in 22 payments from 12 companies in 2025. Trend: 2023 $434 · 2024 $435 · 2025 $1,000
Food & beverage: $975Grant: $25
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories | 5 | $267 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $130 |
| Penumbra, Inc. | 1 | $127 |
| BridgeBio Pharma, Inc. | 1 | $126 |
| Novartis Pharmaceuticals Corporation | 5 | $110 |
| Kestra Medical Technology Services, Inc. | 3 | $86 |
| AstraZeneca Pharmaceuticals LP | 1 | $39 |
| AtriCure, Inc. | 1 | $31 |
| Boston Scientific Corporation | 1 | $25 |
| Shockwave Medical, Inc | 1 | $25 |
Products named: MITRACLIP, Kerendia, Indigo System, Attruby, LEQVIO, Assure WCD, LOKELMA, CARDIOMEMS.
Industry payments across TN — which companies pay providers there.
